Information for "Sorafenib Becomes First Remedy Of Hepatocellular Carcinoma Authorized In Europe"

Jump to navigation Jump to search

Basic information

Display titleSorafenib Becomes First Remedy Of Hepatocellular Carcinoma Authorized In Europe
Default sort keySorafenib Becomes First Remedy Of Hepatocellular Carcinoma Authorized In Europe
Page length (in bytes)1,943
Page ID588
Page content languageen - English
Page content modelwikitext
Indexing by robotsAllowed
Number of redirects to this page0

Page protection

EditAllow all users (infinite)
MoveAllow all users (infinite)
View the protection log for this page.

Edit history

Page creatorValarieMacPherso (talk | contribs)
Date of page creation05:55, 4 February 2020
Latest editorValarieMacPherso (talk | contribs)
Date of latest edit05:55, 4 February 2020
Total number of edits1
Total number of distinct authors1
Recent number of edits (within past 90 days)0
Recent number of distinct authors0